Director-General Ngozi Okonjo-Iweala met on 3 November with CEOs from a range of companies engaged in the production of key COVID-19 therapeutics. The purpose of the meeting was to review current challenges for expanding and diversifying production of therapeutics and explore the potential role of trade policy tools in addressing and overcoming those challenges, especially in light of ongoing discussions among WTO members on extending the TRIPS Decision at the 12th WTO Ministerial Conference (MC12) to COVID-19 diagnostics and therapeutics.
